CURRICULUM VITAE
Christine Hogan MD
Christine Hogan MD
Assistant Professor
Department of Medicine
Division of Infectious Disease
Department of Medicine
Division of Infectious Disease
OFFICE ADDRESS: |
Froedtert East Clinics |
9200 W Wisconsin Ave |
Milwaukee, WI 53226 |
EDUCATION: |
1990 A.B., Harvard University, Cambridge, Massachusetts |
1995 M.D., University of California, San Francisco; San Francisco, California |
POSTGRADUATE TRAINING AND FELLOWSHIP APPOINTMENTS: |
07/1995 - 06/1998 Internship and Residency in Internal Medicine, Primary Care, Massachusetts General Hospital, Boston, MA |
07/1998 - 06/2001 Fellowship in Infectious Diseases, Columbia University College of Physicians and Surgeons; New York Presbyterian Hospital, New York, NY |
FACULTY APPOINTMENTS: |
07/2001 - 07/2005 Instructor in Clinical Medicine, Columbia University, Division of Infectious Diseases, New York, NY |
07/2001 - 07/2006 Associate Physician, The Rockefeller University Hospital, New York, NY |
07/2001 - 06/2004 Clinical Scholar/Research Associate, Aaron Diamond AIDS Research Center, The Rockefeller University, New York, NY |
07/2001 - 08/2006 Assistant Attending, New York Presbyterian Hospital, New York, NY |
07/2005 - 08/2006 Assistant Professor in Clinical Medicine, Columbia University, Division of Infectious Diseases, New York, NY |
08/2006 - Present Adjunct Assistant Professor in Clinical Medicine, Columbia University College of Physicians and Surgeons, Division of Infectious Diseases, New York, NY |
03/2008 - Present Assistant Professor of Medicine, Division of Infectious Diseases-ARCW Medical College of Wisconsin, Milwaukee, WI |
SPECIALTY BOARDS AND CERTIFICATION: |
Board Certified | Issue Date | Expiration |
Internal Medicine (working on recert) | 1998 | 12/2008 |
Infectious Diseases | 2000 | 2021 |
Licensure | Number | Issue Date | Expiration |
Licensed in Medicine, New York | 1998 | None | |
Wisconsin License | 2008 | None | |
AWARDS AND HONORS: |
1986 - 1990 John Harvard and Elizabeth Cary Agassiz Scholarship |
1987 Detur Award for Outstanding Freshman Performance, Harvard College |
1989 Phi Beta Kappa, Inducted Junior Year College |
1990 Magna Cum Laude Senior Thesis, "The Medical Model of Knowledge in George Eliot's Middlemarch and H.G. Wells' Tono-Bungay |
1995 UCSF Alumni Association's Award for Academic Excellence |
1995 Alpha Omega Alpha Member |
2000 GSK Junior Faculty Award- Infectious Diseases |
2005 Ewig Clinical Education Award for outstanding teaching, Columbia University College of Physicians and Surgeons (to provide 3 years of salary support) |
2006 Nominee, Teacher of the Year award by the Columbia University College of Physicians and Surgeons class of 2008, New York City. |
2006 Honoree, American Medical Women's Association, Columbia University, New York City, for contributions to gender equity in medicine. |
2006 Nominee, Daniel V. Kimberg Memorial Junior Faculty Teaching Award, Columbia University College of Physicians and Surgeons, New York City. |
2015 Selected as one of Milwaukee’s Top Doctors in Infectious Disease, As published in Milwaukee Magazine, August 2015 |
2016 Selected as one of Milwaukee’s Top Doctors in Infectious Disease, As published in Milwaukee Magazine, August, 2016 in peer-review process compiled by Castle Connolly Medical, Ltd. |
MEMBERSHIPS IN HONORARY AND PROFESSIONAL SOCIETIES: |
1989 - Present Phi Beta Kappa |
1995 - Present Alpha Omega Alpha |
1998 - Present American College of Physicians-American Society of Internal Medicine |
2012 - Present Infectious Diseases Society of America/HIV Medicine Association |
2016 - Present American Academy of HIV Medicine |
RESEARCH GRANTS/AWARDS/CONTRACTS/PROJECTS: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
INVITED LECTURES/WORKSHOPS/PRESENTATIONS: |
National |
Christine Hogan, MD Lecture on, "Entry Inhibitors: an Update", for Physicians' Resource Network; New York, NY, 01/15/2002 |
Christine Hogan, MD Lecture on, "Acute HIV Infection: Case Presentation", for NY Metro HIV Grand Rounds; New York Academy of Medicine; New York, NY, 06/03/2004 |
Christine Hogan, MD Lecture on, "Current Treatment Guidelines" for symposium entitled "HIV 2003: Current Care Strategies", Nassau University Medical Center; Melville, NY, 06/03/2004 |
COMMITTEE SERVICE: |
Hospital |
01/2002 - 06/2004 Chairperson, Infection Control Committee, The Rockefeller University Hospital |
03/2004 - 06/2004 Member, Medical Staff Executive Committee, The Rockefeller University Hospital |
MCW TEACHING ACTIVITIES: |
Resident and Fellow Education |
07/2010 - Present Substitute clinical preceptor for MCW infectious disease fellow at the AIDS Resource Center of Wisconsin |
EXTRAMURAL TEACHING: |
Medical Student Education |
07/2004 - 07/2006 Columbia University, Course Director for "Microbiology/Infectious Diseases" component of core pathophysiology course for second-year medical students, College of Physicians and Surgeons. (Assistant Director in autumn 2004, Director in 2005. Continued as a lecturer in 2006-2007) |
Resident and Fellow Education |
11/2004 - 07/2006 Columbia University College of Physicians and Surgeons, New York City, Clinical preceptor for infectious disease fellow in the weekly HIV/ID longitudinal clinic |
07/01/2012 - Present Resource Faculty for NRSA Postdoctoral Fellowship Program in HIV Prevention, Center for AIDS Intervention Research, Department of Psychiatry and Behavioral Medicine, Medical College of Wisconsin |
BIBLIOGRAPHY |
Refereed Journal Publications/Original Papers |
1. HOGAN, C., Hammer, S., "Host Determinants in HIV Infection and Disease Part 1: Cellular and Humoral Immune Responses", Ann. Intern. Med. 2001; 134:761-776. |
2. HOGAN, C., Hammer, S., "Host Determinants in HIV Infection and Disease Part 2: Genetic Factors and Implications for Antiretroviral Therapeutics", Ann. Intern. Med. 2001;134:978-996 |
3. Louie M., HOGAN C., DiMascio M., Hurley A., Simon V., Rooney J, Ruiz N., Brun S., Sun E., Perelson A., Ho D., Markowitz M., "Determining the Relative Efficacy of Highly Active Antiretroviral Therapy", J. Infect. Dis. 2003; 187:896-900 |
4. Louie M., HOGAN C., Hurley A., Simon V., Chung C., Padte N., Lamy P., Flaherty J., Coakley D., Di Mascio M., Perelson A., Markowitz M., "Determining the Antiviral Activity of Tenofovir Disoproxil Fumarate in Treatment-naïve chronically HIV-1 Infected Individuals", AIDS 2003; 17:1151-1156. |
5. Di Mascio M., Markowitz M., Louie M., HOGAN C., Hurley A., Chung C., Ho D., Perelson A., "Viral Blip Dynamics During Highly Active Antiretroviral Therapy", J. Virol. 2003, 77(22):12165-72 |
6. Mehandru S., Poles M., Tenner-Racz K., Horowitz A., Hurley A., HOGAN C., Boden D., Racz P., Markowitz M., "Primary HIV-1 Infection is Associated with Preferential Depletion of CD4+ T Lymphocytes from Effector Sites in the Gastrointestinal Tract," J. Exp. Med.2004, 200(6):761-70. |
7. Mehandru S., Wrin T., Galovich J., Stiegler G., Veelar B., Hurley A., HOGAN C., Vasan S., Katinger H., Petropoulos C., Markowitz M., "Neutralization Profiles of Newly Transmitted Human Immunodeficiency Virus Type I by monoclonal Antibodies 2G12, 2FS, and 4E10", J. Virol. 2004, 78(24):14039-42 |
8. Di Mascio M., Markowitz, M. Louie., Hurley A., HOGAN C., Simon V., Follmann D., Ho D., Perelson A., "Dynamics of Intermittent Viremia during Highly Active Antiretroviral Therapy in Patients who Initiate Therapy during Chronic Versus Acute and Early HIV-1 Infection," J. Virol. 2004, 78(19):1056-73. |
9. Shet A., Berry L., Mohri H., Mehandru S., Chung C., Kim A., Jean-Pierre P, HOGAN C., Simon V., Boden D., Markowitz M., "Tracking the Prevalence of Transmitted Antiretroviral Drug-Resistant HIV-1", JAIDS 2006, 41(4):439-446. |
10. Messer, K., Vaida F., HOGAN C., "Robust Analysis of Biomarker Data with Informative Missingness using a Two-stage hypothesis Test in an HIV Treatment Interruption Trial: AIEDRP AIN503/ACTG A5217", Comtemp. Clin. Trials 2006, 27 (6):506-17 |
11. Markowitz M., Vaida F., Hare C.B., Boden D., Mohri H., Hecht F.M., Kalayjian R.C., Conrad A., Mildvan D., Aberg J., HOGAN C., Kilby J.M., Balfour H.H., Schafer K., Richman D., Little S. The virologic and immunologic effects of cyclosporine as an adjunct to antiretroviral therapy in patients treated during acute and early HIV-1 infection. J. Infect. Dis. 2010; 201(9): 1298-302. |
12. Hogan C., DeGruttola V, Sun X, Fiscus S, Del Rio C, Hare CB, Markowitz M, Connick E, Macatangay B, Tashima K, Kallungal B, Camp R, Frazier T, Daar E, Little S. “The Setpoint Study (ACTG A5217) – Effect of Immediate Versus Deferred Antiretroviral Therapy on Virologic Setpoint in Recently HIV-1-Infected Individuals.” J Infect Dis 2012: 205(1): 87-96. |
Abstracts |
1. HOGAN C., Dobkin J., Brudney K., Chiasson M., Woodward M., Hammer S., "Late Presentation of HIV Disease in the Era of Potent Therapy", First IAS Conference on HIV Pathogenisis and Treatment. July 8-11, 2001; Buenos Aires, Argentina. Abstract 315 |
2. HOGAN C., Hurley A, Louie M., Captan B., Chung C., Zhang L., Ho D., Markowitz M., "Treatment of Acute and Early HIV-1 Infection in 132 Subjects with PI-based Regimens", Ninth Conference on Retroviruses and Opportunistic Infections. February 24-28, 2002; Seattle, Washington. Abstract 363-M |
3. Reynes J., Rouzier R., Kanouni T., Baillat V., Baroudy B., Keung A., HOGAN C., Markowitz M., Laughlin M., "SCH C: Safety and Antiretroviral Effects of a CCR5 Receptor Antagonist in HIV-1 Infected Subjects". Ninth Conference on Retroviruses and Opportunistic Infections. February 24-28, 2002; Seattle, Washington. Abstact 1-M |
4. Hecht F., Holte S., Busch M., HOGAN C., Little S., Schacker T., Kilby M., Routy J., Palella F., Conway B., Margolick J., for the AIEDRP Network. "Absence of p31 Band Identifies Persons with Recent HIV Seroconversion", XIV International AIDS Conference. July 7-12, 2002; Barcelona, Spain. abstract TuPeC4885 |
5. HOGAN C., Louie M., Vasan S., Hurley A., Horowitz A., Chung C., Kim A., Di Mascio M., Perelson A., Ho D., Markowitz M. "Assessing the Relative Efficacy of HAART Regimens Using Early Changes in Plasma Viremia." Tenth Conference on Retroviruses and Opportunistic Infections. February 10-14, 2003, Boston, Massachusetts. Abstract 573. |
6. Simon V., HOGAN C., Louie M., Vasan S., Rowe L., Hurley A., Padte N., Vanderhoeven J., Dawson K., Balfe P., Markowitz M., "Frequency of Transmitted Drug Resistance and Identification of Phylogenetic Clusters in a Homogeneous Cohort of Newly Infected Individuals". Tenth Conference on Retroviruses and Opportunistic Infections. February 10-14, 2003; Boston, Massachusetts. Abstract 504. |
7. Vasan S., Siladji E., HOGAN C., Hurley A., Markowitz M., Tsuji M., "NKT Cells are Preserved in Patients Beginning HAART during Acute Infection". Eleventh Conference on Retroviruses and Opportunistic Infections. February 8-11, 2004 San Francisco, California. Abstract 245 |
8. HOGAN C., Hurley A., Vasan S., Mehandru S., Chung C. Markowitz M., "Treatment of Acute and Early HIV-1 Infection with Trizivir/Efavirenz". Second International Workshop on Acute HIV-1 Infection. May 3-4, 2004; Bethesda, MD. Abstract P-18. |
9. Fiscus SA, Cachafeiro A., Kshatriya R., Napravnik S., Owen M., Keating S., Busch M., Little S., HOGAN C., "Comparison of 6 HIV Incidence Assays with the Less Sensitive Vironostika HIV Antibody Assay for Screening Subjects for A5217." 16th Conference on Retroviruses and Opportunistic Infections. February 2009 Montreal, Canada. Abstract V-122. |
10. HOGAN C., DeGruttola V., Daar E., Sun X., Del Rio C., Fiscus S., Frazier T., Hare B., Markowitz M., Little S., "A Finite Course of ART during Early HIV-1 Infection Modestly Delays Need for Subsequent ART Initiation: ACTG A5217, the SETPOINT Study." 17th Conference on Retroviruses and Opportunistic Infections. February 16-19, 2010. San Francisco, California. Paper 134. (This paper has been submitted to a peer-reviewed journal for publication and is currently under review as of July 2011) |